OOIR: Observatory of International Research

Papers

(The median citation count of Presse Medicale is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Contents	54
Contents	50
Long-COVID: Cognitive deficits (brain fog) and brain lesions in non–hospitalized patients	40
Editorial	39
Editorial board	34
Kidney disease in multiple myeloma	31
International variability in the diagnosis and management of disorders of consciousness	31
Autoimmunity in lipodystrophy syndromes	31
History of measles	29
Primary cutaneous lymphoma: the 2018 update of the WHO-EORTC classification	28
Evolving strategies in the management of transplant-eligible patients with newly diagnosed multiple myeloma	24
Editorial board	23
Editorial board	23
Craniopharyngiomas	22
New developments in skin-directed treatments of cutaneous T-cell lymphoma	22
Familial partial lipodystrophy syndromes	22
Editorial board	21
Towards etiological treatments in cardiomyopathies	21
Molecular Imaging in neuroendocrine neoplasias	21
Pulmonary hypertension in sickle cell disease	21
Cholera in Haiti	20
Updates on mechanisms of disease progression in precursor myeloma: Monoclonal gammopathy of undermined significance and smoldering myeloma	20
Prognosis of consciousness disorders in the intensive care unit	18
The current and future contribution of neuroimaging to the understanding of disorders of consciousness	17
Editorial board	17

The deep and the deeper: Spinal cord and deep brain stimulation for neuropathic pain	17
Editorial board	17
Presentation of polymyalgia rheumatica and large joint polyarthritis in the spectrum of hyper-IgG4-related disease: A case report and literature review	17
Heart failure with preserved ejection fraction: New challenges and new hopes	16
Cystic fibrosis	16
Update on the pathogenetic hallmarks of chronic obstructive pulmonary disease	15
Editorial board	13
Effects of thyroid disruption on neural cells stem fate in the mouse brain	13
Generalized lipoatrophy syndromes	12
Cardiac functional imaging	12
Heart failure: A major public health problem	12
Contents	11
Renal hemodynamic changes in patients with type 2 diabetes and their clinical impact	11
Risk stratification of acute pulmonary embolism	11
The Spanish flu	10
COVID-19 and kidney transplantation	9
Contents	9
Letter on the article “Long-COVID: Cognitive deficits (brain fog) and brain lesions in non hospitalized patients”	9
Adrenal functional imaging	9
Contents	9
A tribute to Guy Meyer	9
Sickle cell disease and pregnancy	8
Imaging in multiple myeloma	8
Pituitary adenoma & nuclear medicine: Recent outcomes and ongoing developments	8
Elderly patients with venous thromboembolism: Insights from the RIETE registry	8
Contents	8
Prolactinomas	8
Vascular pathophysiology of sickle cell disease	7
Idiopathic pulmonary fibrosis	7
Metreleptin treatment of non-HIV lipodystrophy syndromes	7
Contents	7
Treatment of elderly and frail myeloma patients	6
The liver in sickle cell disease	6
Bronchiectasis	6
Preventative and curative treatment of venous thromboembolic disease in cancer patients	6
Diagnostic management of acute pulmonary embolism	6
Health technology assessment in France	6
Duration of anticoagulation of venous thromboembolism	5
HIV / AIDS as a model for emerging infectious disease: Origin, dating and circumstances of an emblematic epidemiological success	5
Vascular malformations	5
Functional imaging in thyroid cancer patients with metastases and therapeutic implications	5
Capillary malformations updates on aetiopathogenesis, diagnosis, and management	5
What's new in transplantation?	5
The French way of HTA: Between scientific rigor, independence and transparency	4
Lower-limb peripheral arterial disease and amputations in people with diabetes: Risk factors, prognostic value and management	4
Advancing the management of acute intermediate-high-risk pulmonary embolism: The enduring legacy of Professor Guy Meyer	4
Life and death of smallpox	4
Cushing's disease	4
Primary ciliary dyskinesia	4
Recent insights in pituitary diseases	3

Clinical trials with reno-vascular end points in patients with diabetes: Changing the scenario over the past 20 years	3
Clinical pharmacology of antidiabetic drugs: What can be expected of their use?	3
Integrated care in COPD	3
The European reference network on rare lung diseases (ERN-LUNG) ambition to offer better lung health for all	3
Neuropathic pain: Evidence based recommendations	3
Hypophysitis: A comprehensive overview	3
Bispecific antibody and chimeric antigen receptor (CAR) modified T-cell in the treatment of multiple myeloma: Where do we stand today?	3
Electrical therapies in heart failure: Evolving technologies and indications	3
Editorial	2
Taking ethics into account: the HAS perspective	2
Yellow fever: A brief history of a tropical Virosis	2
Multiple symmetric and multiple familial lipomatosis	2
Patient-reported outcome measures: A key to patient-tailored and outcome-driven care in pulmonary embolism survivors	2
Editorial	2
Health technology assessment in Europe: A comparison of organizations and introduction to the European regulation	2
Functional imaging for hyperparathyroidism	2
Contents	2
Contents	2
Molecular imaging or functional: An increasingly applied method in all fields of medicine	2
Chronic heart failure with reduced EF: A decade of major pharmacological innovations	2
Contents	2